Bengaluru Metro Pink Line Trials To Start End March 2026

28 Mar 2026 CW Team

Bengaluru Metro Rail Corporation Limited (BMRCL) is preparing trial runs on the Pink Line from Kalena Agrahara to Nagawara, with testing expected to start by the end of March 2026. The development marks a key step for the Namma Metro network and has attracted attention from commuters seeking improved north-south connectivity. The corridor spans 21.3 km, with 13.8 km underground and 7.5 km elevated.

Testing will begin on the elevated section between Kalena Agrahara and Tavarekere because elevated tracks require fewer regulatory clearances than tunnels. The phase will assess track strength, train movement and signalling systems alongside mechanical and electrical coordination. Visible progress on the elevated stretch signals that the project is nearing completion.

Work on the underground stretch from Dairy Circle to Nagawara is in the final stages, with BMRCL reporting that track laying and third rail electrification inside tunnels are progressing steadily. Once certified for safety, the underground and elevated sections will be integrated into a single operational line. Two major interchange stations at MG Road, linking to the Purple Line, and Jayadeva Hospital, connecting to the Yellow Line, will allow commuters to switch lines and reduce dependence on road travel.

Commercial operations are targeted by the end of 2026 or early 2027, subject to safety approvals, and the trial phase will be closely watched as an indicator of the timeline. The start of trial runs suggests civil and systems work on the elevated stretch is largely complete and that attention will shift to integrated systems testing and regulatory certification. Commuter expectations include reductions in journey times between Bannerghatta Road and north Bengaluru of two to three hours, reflecting the potential benefits of the Pink Line for travel across the city.

Infrastructure Urban

07 May 2026

Vedanta Reports Record Profit in FY26

Vedanta reported its best-ever financial performance in FY26, with profit after tax of Rs 250.96 billion and revenue of Rs 1.74 trillion, supported by operational excellence across businesses. The company delivered nearly 50 per cent total shareholder return and declared a dividend of Rs 34 per share.Vedanta said its net debt-to-EBITDA improved to 0.95x, strengthening financial flexibility. Its demerger, effective 1 May 2026, is aimed at unlocking value by creating focused businesses across aluminium, oil and gas, power, iron and steel, zinc, copper, nickel and ferro alloys.Vedanta Aluminium p..

KEC Wins Orders Worth Rs 10.02 Billion

KEC International, an RPG Group company and global infrastructure EPC major, has secured new orders worth Rs 10.02 billion across its key businesses.In Transmission and Distribution, the company has won orders for projects in India and the Americas. These include ±500 kV HVDC transmission lines from a private developer in Western India, 132 kV cabling works from a steel producer in Eastern India, and the supply of towers, hardware and poles in the Americas.The renewables business has secured an order for a 100+ MW wind project in Southern India from a private developer. In transportation, KEC..

Hindustan Zinc Opens Cath Lab in Udaipur

Hindustan Zinc recently inaugurated a state-of-the-art Cardiac Catheterisation Laboratory at Rabindranath Tagore Hospital, Udaipur. The facility was inaugurated by Gulab Chand Kataria, Governor of Punjab and Administrator of Chandigarh, in the presence of local MLAs, RNT Hospital leadership and senior Hindustan Zinc officials.The Cath Lab follows an MoU signed earlier between Hindustan Zinc and RNT Hospital for the redevelopment and upgradation of the hospital into a future-ready, multi-speciality healthcare facility. Equipped with advanced cardiac technology, it will support minimally invasiv..